Ocular Therapeutix OCUL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's free cash flow?
- Ocular Therapeutix (OCUL) reported free cash flow of -$70.66M in Q1 2026.
- How has Ocular Therapeutix's free cash flow changed year-over-year?
- Ocular Therapeutix's free cash flow decreased by 51.6% year-over-year, from -$46.6M to -$70.66M.
- What is the long-term trend for Ocular Therapeutix's free cash flow?
- Over 4 years (2021 to 2025), Ocular Therapeutix's free cash flow has grown at a 34.3% compound annual growth rate (CAGR), from -$66.74M to -$216.89M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.